
Paul V. Ward
Examiner (ID: 12069, Phone: (571)272-2909 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1622, 1624, 1623 |
| Total Applications | 2522 |
| Issued Applications | 1807 |
| Pending Applications | 234 |
| Abandoned Applications | 540 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18672128
[patent_doc_number] => 20230309559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHODS OF CONTROLLING OR PREVENTING INFESTATION OF PLANTS BY PLANT-PARASITIC NEMATODES OF THE GENUS APHELENCHOIDES SPP., ESPECIALLY APHELENCHOIDES BESSEYI
[patent_app_type] => utility
[patent_app_number] => 18/042057
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042057 | METHODS OF CONTROLLING OR PREVENTING INFESTATION OF PLANTS BY PLANT-PARASITIC NEMATODES OF THE GENUS APHELENCHOIDES SPP., ESPECIALLY APHELENCHOIDES BESSEYI | Aug 15, 2021 | Pending |
Array
(
[id] => 19675880
[patent_doc_number] => 12187730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Salts of TAM inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/401570
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 28625
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401570
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401570 | Salts of TAM inhibitors | Aug 12, 2021 | Issued |
Array
(
[id] => 17458829
[patent_doc_number] => 20220072133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => Pharmaceutical Compositions Having Improved Storage Stability
[patent_app_type] => utility
[patent_app_number] => 17/398801
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/398801 | Pharmaceutical compositions having improved storage stability | Aug 9, 2021 | Issued |
Array
(
[id] => 18910341
[patent_doc_number] => 11873310
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Compounds useful in HIV therapy
[patent_app_type] => utility
[patent_app_number] => 17/395723
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 54445
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395723 | Compounds useful in HIV therapy | Aug 5, 2021 | Issued |
Array
(
[id] => 17398056
[patent_doc_number] => 20220040146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/396223
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396223 | Antimicrobial compositions and related methods | Aug 5, 2021 | Issued |
Array
(
[id] => 17505067
[patent_doc_number] => 20220098169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/391081
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 332
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391081
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/391081 | ANTIVIRAL AGENTS | Aug 1, 2021 | Abandoned |
Array
(
[id] => 18340423
[patent_doc_number] => 20230132372
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-04-27
[patent_title] => REAGENTS FOR QUANTITATIVE MASS SPECTROMETRY
[patent_app_type] => utility
[patent_app_number] => 17/387888
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387888
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/387888 | Reagents for quantitative mass spectrometry | Jul 27, 2021 | Issued |
Array
(
[id] => 18340423
[patent_doc_number] => 20230132372
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-04-27
[patent_title] => REAGENTS FOR QUANTITATIVE MASS SPECTROMETRY
[patent_app_type] => utility
[patent_app_number] => 17/387888
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387888
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/387888 | Reagents for quantitative mass spectrometry | Jul 27, 2021 | Issued |
Array
(
[id] => 18227777
[patent_doc_number] => 20230066771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => NUCLEAR RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/443264
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443264
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443264 | NUCLEAR RECEPTOR MODULATORS | Jul 22, 2021 | Abandoned |
Array
(
[id] => 18649345
[patent_doc_number] => 20230295139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS
[patent_app_type] => utility
[patent_app_number] => 18/017201
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017201
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017201 | Synthesis of heterocyclic compounds from carboxamide and carboxamide derivatives with haloalkanols | Jul 20, 2021 | Issued |
Array
(
[id] => 17399504
[patent_doc_number] => 20220041594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => PTPN11 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/380943
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17380943
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/380943 | PTPN11 inhibitors | Jul 19, 2021 | Issued |
Array
(
[id] => 17369873
[patent_doc_number] => 20220024925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Compounds and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/380865
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17380865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/380865 | Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Compounds and Uses Thereof | Jul 19, 2021 | Abandoned |
Array
(
[id] => 17655308
[patent_doc_number] => 20220175773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
[patent_app_type] => utility
[patent_app_number] => 17/377885
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377885 | RET inhibitor for use in treating cancer having a RET alteration | Jul 15, 2021 | Issued |
Array
(
[id] => 19579829
[patent_doc_number] => 12145925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 17/376577
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 47004
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/376577 | Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer | Jul 14, 2021 | Issued |
Array
(
[id] => 18484825
[patent_doc_number] => 20230212132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => AMINIMIDE COMPOUND, AMINIMIDE COMPOSITION, CURING AGENT, EPOXY RESIN COMPOSITION, METHOD FOR PRODUCING AMINIMIDE COMPOUND, ENCAPSULANT, AND ADHESIVE
[patent_app_type] => utility
[patent_app_number] => 18/016182
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016182 | AMINIMIDE COMPOUND, AMINIMIDE COMPOSITION, CURING AGENT, EPOXY RESIN COMPOSITION, METHOD FOR PRODUCING AMINIMIDE COMPOUND, ENCAPSULANT, AND ADHESIVE | Jul 13, 2021 | Pending |
Array
(
[id] => 18484825
[patent_doc_number] => 20230212132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => AMINIMIDE COMPOUND, AMINIMIDE COMPOSITION, CURING AGENT, EPOXY RESIN COMPOSITION, METHOD FOR PRODUCING AMINIMIDE COMPOUND, ENCAPSULANT, AND ADHESIVE
[patent_app_type] => utility
[patent_app_number] => 18/016182
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016182 | AMINIMIDE COMPOUND, AMINIMIDE COMPOSITION, CURING AGENT, EPOXY RESIN COMPOSITION, METHOD FOR PRODUCING AMINIMIDE COMPOUND, ENCAPSULANT, AND ADHESIVE | Jul 13, 2021 | Pending |
Array
(
[id] => 18581500
[patent_doc_number] => 20230263752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => VETERINARY COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF PROTOZOAN DISEASES AND METHODS OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/016181
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016181
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016181 | VETERINARY COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF PROTOZOAN DISEASES AND METHODS OF PREPARATION THEREOF | Jul 12, 2021 | Pending |
Array
(
[id] => 17578690
[patent_doc_number] => 20220135545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => POLYMORPHS OF SELINEXOR
[patent_app_type] => utility
[patent_app_number] => 17/365656
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365656
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365656 | Polymorphs of Selinexor | Jun 30, 2021 | Issued |
Array
(
[id] => 18036110
[patent_doc_number] => 20220380325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/363534
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363534 | ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | Jun 29, 2021 | Abandoned |
Array
(
[id] => 17343578
[patent_doc_number] => 20220009909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/364039
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 520
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364039 | ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF | Jun 29, 2021 | Abandoned |